ADME Toxicology Testing Market is expected to grow at the CAGR of 10.2% during 2017-2025
According to a recently published report by Brisk Insights, the global ADME Toxicology Testing Market is expected to grow at the CAGR of 10.2% during 2017-2025. The global ADME toxicology testing market is segmented on the basis of product type, technology type and geography. The report on global ADME toxicology testing market forecast 2017-2025 (by product type, technology and geography) provides a detailed overview and predictive analysis of the market.
Full report available on ADME Toxicology Testing Market: Global Industry Size, Growth, Share and Forecast to 2025 report at http://www.briskinsights.com/report/adme-toxicology-testing-market
Market Insights
ADME toxicology is a novel concept that is being used in market for drug discovery, development and testing in pharmaceutical and biotechnology companies. ADME stands for absorption, distribution, metabolism and elimination process which takes place when drug is consumed by human body. Thus ADME process helps in understanding the drug performance on human tissue. The key drivers of the market include rapid adoption of in silico and in vitro toxicology testing, and cell based assay systems in drug development and discovery and ADME analysis.
Scope of the report
1. Global ADME Toxicology Testing Market, by Product Type, 2015–2025 ($ Million)
1.1. Microarray
1.2. Instruments
1.3. Software Solutions
1.4. Assays Systems
1.5. Reagents
1.6. Others
1.2. Instruments
1.3. Software Solutions
1.4. Assays Systems
1.5. Reagents
1.6. Others
2. Global ADME Toxicology Testing Market, by Technology Type, 2015–2025 ($ Million)
2.1. Oncology
2.2. In-vitro Tests
2.2.1. Biochemical Testing
2.2.2. Cell Testing
2.3. In-vivo Tests
2.2. In-vitro Tests
2.2.1. Biochemical Testing
2.2.2. Cell Testing
2.3. In-vivo Tests
3. Global ADME Toxicology Testing Market, by Geography, 2015-2025 ($ Million)
3.1. North America (U.S. & Canada)
3.2. Europe (U.K., Germany & Rest of Europe)
3.3. Asia Pacific (China, Japan, and Rest of APAC)
3.4. Latin America (Brazil, Mexico and Rest of LATAM)
3.5. Middle East and Africa (UAE, Saudi Arabia, South Africa)
3.2. Europe (U.K., Germany & Rest of Europe)
3.3. Asia Pacific (China, Japan, and Rest of APAC)
3.4. Latin America (Brazil, Mexico and Rest of LATAM)
3.5. Middle East and Africa (UAE, Saudi Arabia, South Africa)
4. Profiles
4.1. Cellartis AB
4.2. Thermo Fisher Scientific, Inc.
4.3. Agilent Technologies, Inc.
4.4. Bio-Rad Laboratories, Inc.
4.5. Caliper Life Sciences, Inc.
4.6. Promega Corporation
4.7. Beckman Coulter, Inc.
4.8. Optivia Biotechnology, Inc.
4.9. Cyprotex PLC
4.10. Molecular Discovery Ltd.
4.11. Others
4.2. Thermo Fisher Scientific, Inc.
4.3. Agilent Technologies, Inc.
4.4. Bio-Rad Laboratories, Inc.
4.5. Caliper Life Sciences, Inc.
4.6. Promega Corporation
4.7. Beckman Coulter, Inc.
4.8. Optivia Biotechnology, Inc.
4.9. Cyprotex PLC
4.10. Molecular Discovery Ltd.
4.11. Others
About Us
Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies. Our team of 200 analysts’ provides enterprises with strategic insights. Brisk Insights works to help enterprises grow through strategic insights and actionable solutions
Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies. Our team of 200 analysts’ provides enterprises with strategic insights. Brisk Insights works to help enterprises grow through strategic insights and actionable solutions
Contact Us:
Office 1094
109 Vernon House
Friar Lane
Nottingham
NG1 6DQ
+448081890034 (UK)
sales@briskinsights.com
Office 1094
109 Vernon House
Friar Lane
Nottingham
NG1 6DQ
+448081890034 (UK)
sales@briskinsights.com
Comments
Post a Comment